The THP-1 cell toolbox: a new concept integrating the key events of skin sensitization.
According to the current scientific consensus, one in vitro test is insufficient to cover the key events (KE) defined by the adverse outcome pathway (AOP) for skin sensitization. To address this issue we combined different end points in the same cell line to cover all KEs defined by the skin sensitization AOP. Since dendritic cells (DC) play a key role in the sensitization phase leading to the development of allergic contact dermatitis (ACD), we used THP-1 cells as a surrogate for DC. We measured ROS production and GSH depletion for KE1 (binding to proteins), Nrf2 activation pathway and gene expressions for KE2 (keratinocyte response), phenotype modifications using cell-surface markers and cytokine production for KE3 (DC activation), and T-cell proliferation for KE4 (T-cell activation). These measurements were performed using the THP-1 cell line and an original THP-1/T-cell co-culture system following exposure to a variety of chemicals, including irritant, non-sensitizers, and chemicals sensitizers (pro/prehaptens). Results showed that treatment with sensitizers such as cinnamaldehyde (100 µM) or methylisothiazolinone (150 µM) was able to trigger the three main key events (KE1, KE2, and KE3) of the sensitization phase of ACD in THP-1 cells. In addition, all sensitizers were able to induce T lymphocyte proliferation (KE4), while non-sensitizers and irritants did not. Our study shows for the first time that addressing the four main KE of skin sensitization AOP in a single cell line is an achievable task.
['Clouet|Elodie|E|', 'Bechara|Rami|R|', 'Raffalli|Chloé|C|', 'Damiens|Marie-Hélène|MH|', 'Groux|Hervé|H|', 'Pallardy|Marc|M|', 'Ferret|Pierre-Jacques|PJ|', 'Kerdine-Römer|Saadia|S|http://orcid.org/0000-0003-3313-952X']
D000073931:Adverse Outcome Pathways D000826:Animal Testing Alternatives D018920:Coculture Techniques D016207:Cytokines D003713:Dendritic Cells D017449:Dermatitis, Allergic Contact D006801:Humans D015603:Keratinocytes D008213:Lymphocyte Activation D051267:NF-E2-Related Factor 2 D018384:Oxidative Stress D017382:Reactive Oxygen Species D012867:Skin D013601:T-Lymphocytes D000074084:THP-1 Cells
THP-1 Adverse outcome pathway Allergic contact dermatitis Co-culture Lymphocyte In vitro sensitization assay